4 resultados para Tuberculosis in cattle
em Repositório Científico do Instituto Politécnico de Lisboa - Portugal
Resumo:
Clustering analysis is a useful tool to detect and monitor disease patterns and, consequently, to contribute for an effective population disease management. Portugal has the highest incidence of tuberculosis in the European Union (in 2012, 21.6 cases per 100.000 inhabitants), although it has been decreasing consistently. Two critical PTB (Pulmonary Tuberculosis) areas, metropolitan Oporto and metropolitan Lisbon regions, were previously identified through spatial and space-time clustering for PTB incidence rate and risk factors. Identifying clusters of temporal trends can further elucidate policy makers about municipalities showing a faster or a slower TB control improvement.
Resumo:
Although vaccination is still the most cost-effective strategy for tuberculosis control, there is an urgent need for an improved vaccine. Current BCG vaccine lacks efficacy in preventing adult pulmonary tuberculosis, the most prevalent form of the disease. Targeting nasal mucosa, Mycobacterium tuberculosis infection site, will allow a simpler, less prone to risk of infection and more effective immunization against disease. Due to its biodegradable, immunogenic and mucoadhesive properties, chitosan particulate delivery systems can act both as carrier and as adjuvant, improving the elicited immune response. In this study, BCG was encapsulated in alginate and chitosan microparticles, via a mild ionotropic gelation procedure with sodium tripolyphosphate as a counterion. The particulate system developed shows effective modulation of BCG surface physicochemical properties, suitable for mucosal immunization. Intracellular uptake was confirmed by effective transfection of human macrophage cell lines.
Resumo:
Next-generation vaccines for tuberculosis should be designed to prevent the infection and to achieve sterile eradication of Mycobacterium tuberculosis. Mucosal vaccination is a needle-free vaccine strategy that provides protective immunity against pathogenic bacteria and viruses in both mucosal and systemic compartments, being a promising alternative to current tuberculosis vaccines. Micro and nanoparticles have shown great potential as delivery systems for mucosal vaccines. In this review, the immunological principles underlying mucosal vaccine development will be discussed, and the application of mucosal adjuvants and delivery systems to the enhancement of protective immune responses at mucosal surfaces will be reviewed, in particular those envisioned for oral and nasal routes of administration. An overview of the essential vaccine candidates for tuberculosis in clinical trials will be provided, with special emphasis on the potential different antigens and immunization regimens.
Resumo:
A intervenção sobre a tuberculose no Rio de Janeiro, Brasil, revela atualmente uma intensificação e alargamento das articulações de pessoas, organizações e instituições envolvidas. Para compreender este processo, recorri ao mapeamento de arenas e mundos sociais. Os mundos sociais definem-se pela partilha de objetivos e de ações, constituindo unidades de ação coletiva. Para atingir os seus objetivos precisam de interagir com outros mundos sociais. Os espaços onde interagem sobre temas de comum interesse, mas sobre os quais têm perspetivas e até objetivos diferentes, denominam-se arenas. O estudo revelou que a arena da tuberculose no Rio de Janeiro se ampliou na última década, aumentando e diversificando os mundos sociais envolvidos, através do “trabalho político” de pessoas e organizações locais, nacionais e internacionais, isto é, através da atribuição de poder a determinadas instâncias com base na valorização ética de objetivos comuns. Este trabalho político tem vindo a implicar a interseção com as arenas do Sistema Único de Saúde e do VIH-Sida. A ampliação da arena da tuberculose redefine a própria doença e as formas de intervir sobre ela. Os apoios socioeconómicos para as/os pacientes, o tratamento de comorbidades, os direitos humanos, bem como outras questões que extravasam a perspetiva biomédica, integram agora as agendas da tuberculose. Neste processo, os intervenientes alargam também as fronteiras da ação na saúde.